AMP vs MET
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AMP's deterministic health score is weak with a Piotroski F-Score of 4/9, indicating borderline financial stability. Despite strong profitability metrics like a 59.59% ROE and solid earnings growth (YoY +86.6%), the stock trades above its Graham defensive value of $235.33 at $496.60, reflecting rich valuation. Earnings volatility, declining recent estimate beats, and bearish insider activity offset strong cash flow efficiency and low leverage. Analysts concur with a 'hold' rating, aligning with technical bearishness and mixed fundamentals.
MET shows neutral fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Mixed signals with both opportunities and risks present.
Compare Another Pair
Related Comparisons
AMP vs MET: Head-to-Head Comparison
This page compares Ameriprise Financial, Inc. (AMP) and MetLife, Inc. (MET) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.